Trending...
- UK Financial Ltd Board of Directors Establishes Official News Distribution Framework and Issues Governance Decision on Official Telegram Channels
- Naturism Resurgence (NRE) Announces the World's First Standardised Stigma Measure (SSM) for Naturism
- UK Financial Ltd Confirms Official Corporate Structure of the Maya Preferred Project and Its Dual-Class Token System
SYDNEY - AussieJournal -- Today, the Australian Chiropractors Association (ACA) launched national Spinal Health Week (20 - 26 May 2024) with the release of new independent findings on the prevalence of back pain due to spine related musculoskeletal disorders (MSDs).
The Impact of Back Pain & Musculoskeletal Injuries in Australia, an independent national consumer survey conducted by Pureprofile, revealed that of the 1006 respondents, over 98% (98.5% of women and 98.0% of men) experienced a back related MSD in the past 12 months.
Of all respondents, 30% reported low back pain as the most chronic (long-lasting) MSD condition. 28% reported experiencing moderate low back pain which interfered significantly with daily life, while 35% of low back pain sufferers classified the pain as moderate and 8% said it was severe.
According to the ABS (Oct 2023), in June 2023, Australia had 10.4 million households. With over 80% of survey respondents reporting that their household had occupants who experienced back pain, this figure suggests that 8.35 million Australian households are likely to have residents who suffer back pain.
Dr David Cahill, President of the ACA said, "Of concern is the survey showed that a large number (50%) of MSD sufferers had failed to seek a medical diagnosis, while 64% of low back pain sufferers also reported not seeking a diagnosis suggesting that official data may not reflect the true prevalence of MSDs and back pain in Australia."
More on Aussie Journal
The first World Health Organisation (WHO) guideline for non-surgical management of chronic primary low back pain in adults in primary and community care settings (Dec 2023), developed from in depth research by a world-wide range of neuro-musculoskeletal health practitioners including chiropractors; recommends optimising the clinical management of people with chronic primary low back pain or non-specific low back pain, as a priority for WHO Member States.
However, 81% of low back pain sufferers opted to treat symptoms with over the counter or prescription medications rather than seek treatment, with 13% using pain relief medications daily, 12% using it frequently (3+ days per week) and 12% taking pain relief medications often (one to two times per week).
Significantly, women reported the greatest use of pain relief medication for low back pain (82.2%) with 14% taking it daily, 13% frequently and 13.5% said they used medication to relieve back pain often.
Although older Australians are considered high risk for MSDs and low back pain, others most at risk include those who do strenuous physical work including lifting, repetitive actions or standing for extended periods.
Inactive Australians who don't exercise and spend long hours sitting at work or at home are also at risk of developing musculoskeletal problems that can impact their quality of life and overall health and wellbeing.
According to the survey, 6,368 MSDs were reported. The dominant three MSDs impacting the lives of Australian's were low back pain (80.6%), neck pain (67.9%) and mid back pain (66.3%). 75% of respondents aged 18-60 within the peak working age reported back pain with 17.9% of MSDs requiring workers compensation.
More on Aussie Journal
For those who experience persistent symptoms beyond three months, known as chronic primary low back pain, the pain is often not caused by any particular condition.
Dr Cahill said, "While the annual cost of MSDs to the Australian economy exceeds $55.1 billion in direct health costs, lost productivity, reduced quality of life and increased disability, the personal cost to sufferers of persistent low back pain can be life-limiting having a negative impact on their mental health and overall wellbeing while placing a substantial financial burden on families, communities, and our healthcare system."
The survey results, together with the World Health Organisation's (WHO) analysis that MSDs account for the greatest proportion of persistent pain conditions and are the second largest contributor to disability worldwide with low back pain the single leading cause of disability globally; form a compelling case for a proactive, strategic response to how Australians approach back pain.
Seeking appropriate healthcare options that can limit the use of medications by treating the cause of the condition with recommended exercises can help prevent reoccurrence.
For more visit: www.spinalhealthweek.org.au
Media Centre: https://bit.ly/SHW-24
The Impact of Back Pain & Musculoskeletal Injuries in Australia, an independent national consumer survey conducted by Pureprofile, revealed that of the 1006 respondents, over 98% (98.5% of women and 98.0% of men) experienced a back related MSD in the past 12 months.
Of all respondents, 30% reported low back pain as the most chronic (long-lasting) MSD condition. 28% reported experiencing moderate low back pain which interfered significantly with daily life, while 35% of low back pain sufferers classified the pain as moderate and 8% said it was severe.
According to the ABS (Oct 2023), in June 2023, Australia had 10.4 million households. With over 80% of survey respondents reporting that their household had occupants who experienced back pain, this figure suggests that 8.35 million Australian households are likely to have residents who suffer back pain.
Dr David Cahill, President of the ACA said, "Of concern is the survey showed that a large number (50%) of MSD sufferers had failed to seek a medical diagnosis, while 64% of low back pain sufferers also reported not seeking a diagnosis suggesting that official data may not reflect the true prevalence of MSDs and back pain in Australia."
More on Aussie Journal
- VSee Health (N A S D A Q: VSEE) Secures $6.0M At-Market Investment, Accelerates Expansion as Revenues Surge
- Children Rising Appoints Marshelle A. Wilburn as New Executive Director
- Fairmint CEO Joris Delanoue Elected General Director of the Canton Foundation
- Sleep Basil Mattress Co.'s Debuts New Home Page Showcasing Performance Sleep Solutions for Active Denver Lifestyles
- Bent Danholm Joins The American Dream TV as Central Florida Host
The first World Health Organisation (WHO) guideline for non-surgical management of chronic primary low back pain in adults in primary and community care settings (Dec 2023), developed from in depth research by a world-wide range of neuro-musculoskeletal health practitioners including chiropractors; recommends optimising the clinical management of people with chronic primary low back pain or non-specific low back pain, as a priority for WHO Member States.
However, 81% of low back pain sufferers opted to treat symptoms with over the counter or prescription medications rather than seek treatment, with 13% using pain relief medications daily, 12% using it frequently (3+ days per week) and 12% taking pain relief medications often (one to two times per week).
Significantly, women reported the greatest use of pain relief medication for low back pain (82.2%) with 14% taking it daily, 13% frequently and 13.5% said they used medication to relieve back pain often.
Although older Australians are considered high risk for MSDs and low back pain, others most at risk include those who do strenuous physical work including lifting, repetitive actions or standing for extended periods.
Inactive Australians who don't exercise and spend long hours sitting at work or at home are also at risk of developing musculoskeletal problems that can impact their quality of life and overall health and wellbeing.
According to the survey, 6,368 MSDs were reported. The dominant three MSDs impacting the lives of Australian's were low back pain (80.6%), neck pain (67.9%) and mid back pain (66.3%). 75% of respondents aged 18-60 within the peak working age reported back pain with 17.9% of MSDs requiring workers compensation.
More on Aussie Journal
- Perth Author Launches Debut Novel Half Dream, Half Reality — Romance Meets Men's Mental Health
- AXT Supplies Larvotto with Australia's First onsite ECORE LIBS Core Scanning Technology
- The Nature of Miracles Celebrates 20th Anniversary Third Edition Published by DreamMakers Enterprises LLC
- ICHRRF deplores the Hannukah terrorist attack on Jewish community at Bondi Beach, Australia
- Artificial Intelligence Leader Releases Children's Book on Veterans Day
For those who experience persistent symptoms beyond three months, known as chronic primary low back pain, the pain is often not caused by any particular condition.
Dr Cahill said, "While the annual cost of MSDs to the Australian economy exceeds $55.1 billion in direct health costs, lost productivity, reduced quality of life and increased disability, the personal cost to sufferers of persistent low back pain can be life-limiting having a negative impact on their mental health and overall wellbeing while placing a substantial financial burden on families, communities, and our healthcare system."
The survey results, together with the World Health Organisation's (WHO) analysis that MSDs account for the greatest proportion of persistent pain conditions and are the second largest contributor to disability worldwide with low back pain the single leading cause of disability globally; form a compelling case for a proactive, strategic response to how Australians approach back pain.
Seeking appropriate healthcare options that can limit the use of medications by treating the cause of the condition with recommended exercises can help prevent reoccurrence.
For more visit: www.spinalhealthweek.org.au
Media Centre: https://bit.ly/SHW-24
Source: Australian Chiropractors Association
Filed Under: Health
0 Comments
Latest on Aussie Journal
- TPD Claims following a Psychological Injury
- IODefi Introduces New Web3 Infrastructure Framework as XRP Ledger Development Gains Global Attention
- Terizza Forms Strategic Collaboration with UC San Diego to Pioneer Next-Generation Distributed AI Infrastructure
- EnergyStrat Launches Global LNG Risk Outlook 2025–2030
- Strong Revenue Gains, Accelerating Growth, Strategic Hospital Expansion & Uplisting Advancements: Cardiff Lexington Corporation (Stock Symbol: CDIX)
- Holiday Decorations Most Likely to Cause Injuries
- UK Financial Ltd Confirms Official Corporate Structure of the Maya Preferred Project and Its Dual-Class Token System
- CCHR Florida Joins Global Call to Ban Electroshock Treatment, Citing New Evidence of Widespread Patient Harm
- BoxingRx Announces Full Gym Renovation Ahead of New Ownership's One-Year Anniversary
- UK Financial Ltd Announces It's Official Corporate Headquarters In The United Kingdom
- Rigani Press Announces Breakthrough Book for Health IT and Medical Leaders to Forge the Road to Responsible AI
- FreeTo.Chat - The bold, Anonymous Confession Platform, ushers in a new era of tension relief
- Hyatt House Fresno Celebrates Grand Opening, Introducing the First Hyatt House in Fresno, California
- "I Make Music Not Excuses" Journal by Anthony Clint Jr. Becomes International Amazon Best Seller, Empowering Music Creators Worldwide
- DanReDev, Kaufman Development & Oldivai Announce Major 2026 Projects Nationwide
- Accelerating Precious Metals Expansion and Digital Asset Innovation Ahead of 2026: Asia Broadband Inc. (Stock Symbol: AABB)
- Conserv Brands Completes Acquisition of International Marketing Concepts
- Harmoniq Bio-Signalling Patches Win Global Product Sustainability Awards
- Naturism Resurgence (NRE) Announces the World's First Standardised Stigma Measure (SSM) for Naturism
- London Art Exchange Emerges as a Leading Force in UK Contemporary Art, Elevating Three Artists to Secondary-Market Success
